KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Acquisitions (2016 - 2025)

Evolent Health (EVH) has 11 years of Acquisitions data on record, last reported at $1.4 million in Q4 2025.

  • For Q4 2025, Acquisitions fell 89.85% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $57.4 million, up 86.96%, while the annual FY2025 figure was $57.4 million, 86.96% up from the prior year.
  • Acquisitions reached $1.4 million in Q4 2025 per EVH's latest filing, up from -$2000.0 in the prior quarter.
  • Across five years, Acquisitions topped out at $386.7 million in Q1 2023 and bottomed at -$2000.0 in Q3 2025.
  • Average Acquisitions over 5 years is $45.5 million, with a median of $4.5 million recorded in 2025.
  • Peak YoY movement for Acquisitions: skyrocketed 552362.86% in 2023, then tumbled 100.02% in 2025.
  • A 5-year view of Acquisitions shows it stood at $47.1 million in 2021, then plummeted by 93.44% to $3.1 million in 2022, then tumbled by 50.74% to $1.5 million in 2023, then skyrocketed by 805.26% to $13.8 million in 2024, then crashed by 89.85% to $1.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Acquisitions were $1.4 million in Q4 2025, -$2000.0 in Q3 2025, and $51.5 million in Q2 2025.